Pedmarqsi 欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

pedmarqsi

fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - svi ostali terapeutski proizvodi - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.

PAN-PENI G SODIUM 1M i.j. Prašak za rastvor za injekciju/infuziju 黑山共和国 - 克罗地亚文 - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

pan-peni g sodium 1m i.j. prašak za rastvor za injekciju/infuziju

"farmont m.p." d.o.o. za proizvodnju, promet i usluge, export-import danilovgrad - benzilpenicilin - prašak za rastvor za injekciju/infuziju - 1m i.j.

Sodium Citrate H.I.E.R., 10x /500 ml 克罗地亚 - 克罗地亚文 - HALMED (Agencija za lijekove i medicinske proizvode)

sodium citrate h.i.e.r., 10x /500 ml

emergo europe molen straat 15 2513 bh the hague nizozemska -

Sodium Iodide (I131) Capsules T kapsula, tvrda 波斯尼亚和黑塞哥维那 - 克罗地亚文 - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

sodium iodide (i131) capsules t kapsula, tvrda

inel d.o.o - natrijum jodid (131 i) - kapsula, tvrda - 1 kapsula tvrda sadrži: rastvor natrijumjodida, radioaktivnosti 37 mbq 7400 mbq na dan kalibracije

Vantavo (previously Alendronate sodium and colecalciferol, MSD) 欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

vantavo (previously alendronate sodium and colecalciferol, msd)

n.v. organon - alendronic kiseline, colecalciferol - osteoporoza, postmenopauzalna - lijekovi za liječenje bolesti kostiju - liječenje osteoporoze u postmenopauzi u bolesnika s rizikom od insuficijencije vitamina d. vantavo smanjuje rizik od prijeloma kralježnice i kukova . liječenje постменопаузального osteoporoze kod bolesnika koji ne primaju vitamina d prehrani i rizika vitamina d bubrega. vantavo smanjuje rizik od prijeloma kralježnice i kukova .

Sugammadex Mylan 欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

sugammadex mylan

mylan ireland limited - sugammadex sodium - neuromuskularna blokada - svi ostali terapeutski proizvodi - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Fresenius Kabi 欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

sugammadex fresenius kabi

fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskularna blokada - svi ostali terapeutski proizvodi - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Amomed 欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

sugammadex amomed

aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskularna blokada - svi ostali terapeutski proizvodi - uklanjanje neuromuskularne blokade izazvane rokoronom ili vekuronomom. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Piramal 欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

sugammadex piramal

piramal critical care b.v. - sugammadex sodium - neuromuskularna blokada - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

Sugammadex Adroiq 欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

sugammadex adroiq

extrovis eu ltd. - sugammadex sodium - neuromuskularna blokada - svi ostali terapeutski proizvodi - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.